Plain-English translation of NCT00001281 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study invites people with HIV, people without HIV, and people with other immune system conditions to donate blood samples. Researchers will use these samples to study how HIV affects the body's immune cells, which will help them develop better treatments and understand why some people are more affected by HIV than others.
Scientists don't have a good animal model to study HIV in the laboratory, so they need human blood samples to understand how the virus works. This knowledge is essential for developing new and better treatments for people living with HIV.
You likely qualify if…
You likely don't qualify if…
Your participation would involve visiting a clinic to have blood samples drawn. The researchers will ask you questions about your health history and may screen you for hepatitis. Your blood samples will be studied in the laboratory to help scientists understand how HIV affects immune cells, and samples may also be used for future HIV research with your permission.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
United States
Collaborators
Medstar Health Research Institute
Enrollment target
~2,419 participants
Started
March 1993
Age range
18 Years – 120 Years
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Catherine A Seamon, R.N.
National Institute of Allergy and Infectious Diseases (NIAID)
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.